Following non-submission
AWMSG advice |
||
Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, esketamine hydrochloride (Vesierra®) cannot be endorsed for use within NHS Wales for the induction and maintenance of general anaesthesia, as the only anaesthetic or in combination with another anaesthetic, anesthesia and pain relief (analgesia) in emergency medicine and supplementation of regional or local anaesthesia. |
||
|
||
Medicine details |
||
Medicine name | esketamine hydrochloride (Vesierra®) | |
Formulation | 5 mg/ml solution for injection | |
Reference number | 2337 | |
Indication | Induction and maintenance of general anaesthesia, as the only anaesthetic or in combination with another anaesthetic, anesthesia and pain relief (analgesia) in emergency medicine and supplementation of regional or local anaesthesia |
|
Company | Pfizer Ltd | |
BNF chapter | Anaesthesia | |
Assessment type | Non-submission | |
Status | Not endorsed (Statement of Advice) | |
Date of issue | 06/12/2013 |